These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9333593)

  • 1. [Magnesium deficiency and magnesium substitution. Effect on ventricular cardiac arrhythmias of various etiology].
    Zehender M; Meinertz T; Just H
    Herz; 1997 Jun; 22 Suppl 1():56-62. PubMed ID: 9333593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M
    Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of magnesium on sustained ventricular tachycardia].
    Manz M; Jung W; Lüderitz B
    Herz; 1997 Jun; 22 Suppl 1():51-5. PubMed ID: 9333592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome.
    Kurita T
    Magnes Res; 1994 Jun; 7(2):155-7. PubMed ID: 7999530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medicamentous anti-arrhythmia therapy. Is oral adjuvant therapy with electrolytes of value?].
    Haberl R
    Herz; 1997 Jun; 22 Suppl 1():77-80. PubMed ID: 9333595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of magnesium in intensive care medicine].
    Lüderitz B; Manz M
    Z Kardiol; 1994; 83 Suppl 6():121-6. PubMed ID: 7863684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators.
    Zehender M; Meinertz T; Faber T; Caspary A; Jeron A; Bremm K; Just H
    J Am Coll Cardiol; 1997 Apr; 29(5):1028-34. PubMed ID: 9120155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
    Vester EG
    Herz; 1997 Jun; 22 Suppl 1():40-50. PubMed ID: 9333591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of K+ and Mg2+ in treatment of acute myocardial infarct].
    Kunert M; Scheuble L; Stolzenburg H; Gülker H
    Herz; 1997 Jun; 22 Suppl 1():63-72. PubMed ID: 9333594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of magnesium in cardiac arrhythmias].
    Stühlinger HG; Kiss K; Smetana R
    Wien Med Wochenschr; 2000; 150(15-16):330-4. PubMed ID: 11105328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G; Greene HL
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy monitoring in cardiac arrhythmias: guidelines for evaluation of anti-arrhythmia effects].
    Hief C; Podczeck A; Frohner K; Nürnberg M; Kaltenbrunner W; Steinbach K
    Wien Med Wochenschr; 1994; 144(14-15):379-81. PubMed ID: 7825329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmural dispersion of repolarization determines scroll wave behavior during ventricular tachyarrhythmias.
    Haraguchi R; Ashihara T; Namba T; Tsumoto K; Murakami S; Kurachi Y; Ikeda T; Nakazawa K
    Circ J; 2011; 75(1):80-8. PubMed ID: 21099125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnesium in cardiology].
    Weiss M
    Praxis (Bern 1994); 1995 May; 84(18):526-32. PubMed ID: 7754271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.